The global capillary electrophoresis market is projected to reach $586.9 million in terms of revenue by 2031 at a CAGR of 5.66%, reveals the premium market intelligence study by BIS Research.
Capillary electrophoresis encompasses a rapidly evolving range of consumables, software, and systems. These systems facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences.
Capillary electrophoresis also offers prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy, and is broadly used for nucleic acid analysis and protein analysis applications.
The detailed study is a compilation of 11 Market Data Tables and 152 Figures spread through 177 Pages and in-depth TOC on “Global Capillary Electrophoresis Market– Analysis and Forecast, 2020-2031”
USP of the Report
This extensive report can help with:
Analyst’s Take on the Market:
According to Nitish Kumar Singh, Principal Analyst – BIS Research, states, “North America is the leading contributor in the global capillary electrophoresis market. It contributed approximately 39.75% to the global market value in 2020. This region is anticipated to grow at a CAGR of 6.05% during the forecast period 2021-2031 and will continue dominating the global market in 2031. However, the Asia-Pacific region is expected to grow at an impressive CAGR of 6.10% during the forecast period from 2021 to 2031.”
View the report from BIS Research on Global Capillary Electrophoresis Market
Key Companies Operating in the Market and Competition Landscape
Key insights have been drawn from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The key players profiled in the report include QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Bio-Techne, PerkinElmer Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, Hitachi Ltd., Teledyne Technologies Incorporated, Helena Laboratories, BiOptic Inc., and LABGENE Scientific SA.
Key Questions Answered in the Report:
BIS Research Related Market Studies:
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.
Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.
BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.
Head of Marketing
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch